Events & News

Bioscript and Valid Insight
We Are Joining the Bioscript Group
August 10, 2021

Valid Insight are delighted to announce that we are joining the Bioscript group. Valid Insight will be the latest addition to the Bioscript Group as they extend their services in global market access consulting and payer value communications. We are looking forward to the exciting journey ahead and to building our partnership with Bioscript. Valid […]

Virtual Meetings Market Access
Using TRAVELLESS™ to provide tailored pharmaceutical training
May 20, 2020

In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry. With […]

Pharmaceutical Management
Valid Insight to contribute to Advanced Master’s in Biotechnology & Pharmaceutical Management programme
April 9, 2020

At Valid Insight, we’re pleased to announce that in May 2020, we’ll be providing a series of specialist Market Access lectures as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a leading French graduate business school.  Thanks to our TRAVELLESS™ solution, our trusted virtual platform that we […]

Valid Insight Market Access
Discover Valid Insight: a global market access company
March 23, 2020

From years of experience in market access and the pharmaceutical industry, to our trusted client partnerships, we share our insights into what we believe has led to the team’s success and growth over the years.

Valid Insight Pharmaceutical Pricing Market Access
Expert insights into pharmaceutical pricing and market access

Valid Insight’s Senior Executive Advisor, Raf De Wilde, has over 40 years’ experience in the pharmaceutical industry and over 30 years’ experience in global market access. Watch our video as he shares his expert insights in pharmaceutical pricing and market access:

Valid Insight Queens Award
Valid Insight Queen’s Award presentation: recognising a market access company

Take a look at the very moment that one of the most esteemed business awards, the Queen’s Award for Enterprise in International Trade 2019, was presented to our team.

Valid Insight, market access company, wins Queen’s Award for Enterprise 2019

In October 2019, Valid Insight received the Queen’s Award for Enterprise in International Trade – recognised globally as one of the highest accolades for business success. Our video captures the best moments from the award ceremony. Watch it here:

Queens Award Valid Insight
Inside the Valid Insight Queen’s Award Ceremony
December 4, 2019

In April this year, Valid Insight were awarded the Queen’s Award for Enterprise in International Trade 2019 – the UK’s most esteemed business award, given only to those companies who have demonstrated outstanding results in their field and achieved significant growth and success over three years. Winning this award is invaluable to our team and […]

Valid Insight Queens Award
The Valid Insight visit to Buckingham Palace
September 2, 2019

In April, it was announced that the Valid Insight team had been awarded the Queen’s Award for Enterprise in International Trade. It was an amazing moment for us all. It was not only a testament to the team’s hard work and indisputable expertise, but to our clients’ trust in us to help them to keep […]

Raf De Wilde
Raf De Wilde delivers a masterclass for MSc students in Germany
July 9, 2019

As part of our corporate responsibility to bring new talent in to the industry, our Senior Executive Advisor, Raf De Wilde, will be returning to the University of Duisburg-Essen to deliver a one-day masterclass on patient-reported outcomes and real-world evidence for students studying a Master of Science (MSc) in Pharmaceutical Medicine. We look forward to […]

Valid Insight Market Access
Carolyn Steeds featured in the 2nd Edition of Medical Writing in HEOR/Market Access Guide
June 21, 2019

The second edition of the medical writing in HEOR/Market Access careers guide was launched in June 2019.  This guide focuses on medical writing roles in the HEOR/market access arenas, but will be of interest to anyone who wants to understand more about the business of ensuring access to new medicines and devices for patients. If you have […]

Valid Insight Market Access
Press Release: Valid Insight wins the Queen’s Most Coveted Award for Enterprise
April 23, 2019

The Queen’s Awards for Enterprise are the UK’s most esteemed business awards, presented only to the most eminent of companies or individuals, demonstrating outstanding results in their field. Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s […]

Valid Insight Team Raising Funds for Charity
Rattling the tins: Valid Insight collects donations for Leuka
August 9, 2018

Leukaemia is the 12th most common cancer in Europe, and the 11th most common worldwide. Leuka is a specialist leukaemia charity (now part of Leukaemia UK), investing in the next generation of leukaemia research talent in the UK and beyond. In 2017, Leuka raised nearly £1 million for research, and awarded £2.2 million to blood […]

specialist global market access consultancy
Valid Insight joins the Scottish Life Sciences Association
July 24, 2018

Valid Insight, a specialist global market access consultancy firm with Europe based staff, including London, Belgium and Scotland, has joined the Scottish Lifesciences Association, in order to develop its role in life sciences in the region’s hubs, and to support the fast-growing local industry. “SLA is the voice of Scotland’s vibrant life sciences industries to […]

Market Access Experts
Valid Insight welcomes Frank Cousins as Senior Director
July 16, 2018

Valid Insight, the specialist global market access consultancy, are excited to announce that we have appointed Frank Cousins as Senior Director. Frank has over 20 years’ experience as a consultant to the pharmaceutical industry, specialising in the integration of regulatory strategy, evidence generation and market access for optimal launch and commercial planning. Frank Cousins will […]

Pharma Market Access Consultancy
We are recruiting
December 22, 2017

As a rapidly growing pharma market access consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about market access, with demonstrable knowledge and experience in delivering international projects that make a difference, we’d love to hear from you. To learn more about what we […]

Valid Insight Market Access
Valid Insight’s new appointments confirm its strength in market access and value
September 5, 2017

LONDON, UK – Just 18 months after its February 2016 launch, market access consultancy Valid Insight is pleased to announce the appointment of two new senior people to its rapidly expanding team. Dominic Jones-Phillips and James Wright bring decades of specialist experience from industry. Dominic Jones-Phillips and James Wright will lead global pricing, reimbursement, and […]

Pharma Market Access Consultancy
We’re going from strength to strength – want to join us?
March 3, 2017

Current vacancies:  Director, Market Access & Pricing Principal Consultant, Market Access & Pricing Senior Market Access & Payer Research Consultant Location: Europe-wide As a rapidly growing Pharma Market Access Consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about Market Access, with demonstrable knowledge […]

Market Access Experts
Announcing the launch of Valid Insight
February 14, 2016

Dr Steve Bradshaw, leading a team of key life science advisors and market access experts, has launched Valid Insight, a new market access consultancy created to help companies navigate the challenges faced by drug developers seeking market access for new and innovative therapeutics. Getting a new drug to market and to patients who need better medicines […]